May 18, 2020
Oculis Reports Positive Top-line Data From SKYGGN (Phase 2) Trial With OCS-01 for Treating Inflammation and Pain Following Cataract Surgery
Mar 04, 2020
Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP 30mg/mL, 1mL Fill/2mL Vials Due to the Potential Presence of Small Particulates
Jan 29, 2020
Promising Results From Human PK Study Assessing Novel Ketorolac Formulations for Treatment of Pain
Apr 30, 2019
Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
Jan 07, 2019
Neumentum Phase I Study Confirms Its Non-Opioid in Development for Moderately Severe Acute Pain, NTM-001, Performs in Healthy Adults as Predicted
Dec 13, 2018
Nephron Pharmaceuticals Corporation Releases Opioid Free Pain Management Product: BKK
Sep 20, 2018
AngelMD Investor Group Closes Funding in Neumentum, Inc.
Sep 06, 2018
Neumentum Announces Dosing of Patients in Phase I Study Evaluating Its Lead Product Candidate, NTM-001, a Non-Opioid in Development for the Management of Moderately Severe Acute Pain
May 29, 2018
Egalet Announces Large Regional Plan to Cover SPRIX® Nasal Spray
Jan 23, 2018
Egalet's Partner OraPharma Begins Promotion of SPRIX® Nasal Spray
Jan 03, 2018
Egalet Partners with OraPharma to Co-Promote SPRIX® Nasal Spray
Sep 05, 2017
Egalet's Partner Ascend Therapeutics® U.S., LLC Begins Promotion of SPRIX® Nasal Spray
Aug 30, 2017
Ophthalmic Drugs Market Forecast 2016-2026
Jun 07, 2017
Egalet Partners with Ascend Therapeutics® U.S., LLC to Co-Promote SPRIX® Nasal Spray